Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-23
1991-06-04
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514412, 435184, 435183, 435119, 435200, 548452, C12N 999, C12P 1718, C07D20904, C07D20952
Patent
active
050214276
ABSTRACT:
The present invention involves a purified bioactive compound of the formula: ##STR1## wherein at least one of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are H or an acyl having less than about five carbon atoms. More specifically the preferred purified bioactive compound is (1R, 1R, 3R, 7S, 7aR)-3-hydroxymethyl-1,2,7-trihydroxypyrrolizidine.
REFERENCES:
patent: 4454327 (1984-06-01), Butler et al.
patent: 4792558 (1988-12-01), Sunkara et al.
patent: 4849430 (1989-07-01), Fleet et al.
Pan et al., Biochemistry, vol. 22(16), 1983, pp. 3975-3984.
Sunkara et al., Biochemical and Biophysical Research Communications, vol. 148(1), 1987, pp. 206-210.
Walker et al., Proc. Natl. Acad. Sci., vol. 84, 1987, pp. 8120-8124.
Nash et al., Chemical Abstracts, vol. 110(11); Mar. 13, 1989; pp. 411-412; #92034e.
Nash et al., Chemical Abstracts, vol. 109(13); Sep. 26, 1988; p. 370; #107724k.
Elbein et al., Biochemistry 26, 2502-2510 (1987), "Effect of Isomers of Swainsonine on Glycosidase Activity and Glycoprotein Processing".
Nash, et al., "Isolation from Alexa Leiopetala and X-Ray Crystal Structure of Alexine (1R, 2R, 3R, 7S, 8S)-3-Hydroxymethyl-1,2,7-Trihydroxypyrrolizidine [(2R, 3R, 4R, 5S, 6S)-2-Hydroxymethyl-1-Azabicyclo[3.3.0]Octan-3,4,6-Triol], a Unique Pyrrolizidine Alkaloid" Tetrahedron Lett. 29, 2487-2490 (1988).
CRC Handbook of Chemistry and Physics, 5th Edition, 1964, p. c-15.
Hohenschutz et al., Phytochemistry, vol. 20 (1981) 811-814.
Saul et al., Arch. Biochem. Biophys., vol. 221 (1983) 593-597.
Saul et al., Arch. Biochem. Biophys., vol. 230 (1984) 668-675.
Dreyer, et al., J. Chem. Ecol., vol. 11 (1985) 1045-1051.
Nash, et al., Entomol., vol. 42 (1986) 71-77.
Stevens et al., J. Chem. Ecol., vol. 14 (1988) 1467-1473.
Rhinehart et al., Life Sci., vol. 41 (1987) 2325-2331.
Ostrander et al., Can. Res., vol. 48 (1988) 1091-1094.
Molyneux et al., Science, vol. 216 (1982) 190-191.
Colegate et al., Aust. J. Chem., vol. 32 (1979) 2257-2264.
Humphries et al., Can. Res., vol. 48 (1988) 1410-1415.
Molyneux et al., J. Natural Products, vol. 51 (1988) 1198-1206.
Molyneux et al., Arch. Biochem. Biophys., vol. 251 (1986) 450-457.
Evans et al., Tetrahedron Lett., vol. 26 (1985) 1465-1468.
Molyneux et al., in Plant Toxicology, Seawright, Hegarty, James and Keller, ed. Queensland Poisonous Plants Comm., Brisbane, Australia (1985) 266-278.
Sawhney et al., Aust. J. Chem., vol. 27 (1974) 1805-1808.
Tropea et al., 17th Annual Meeting of Society for Complex Carbonhydrates, San Antonio, Texas, Nov. 3-5, 1988, Abstract No. 8.
Saul et al., Proc. Natl. Acad. Sci. U.S.A., vol. 82 (1985) 93-97.
Dialog Search Report.
Elbein Alan D.
Tropea Joseph E.
Brown Johnnie R.
The Board of Regents The University of Texas System
Webber Pamela S.
LandOfFree
Novel pyrrolizidine alkaloid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel pyrrolizidine alkaloid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel pyrrolizidine alkaloid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026572